NCT05537090View on ClinicalTrials.gov

A Study to Assess Effect of BV100 on the Pharmacokinetics of Midazolam in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

July 31, 2023

Study Completion Date

September 30, 2023

Conditions
Healthy Volunteers
Interventions
DRUG

BV100

Rifabutin for Infusion

DRUG

Midazolam

Syrup for oral administration

Trial Locations (1)

H-2143

CRU Hungary Kft., Early Phase Unit, Kistarcsa

Sponsors

Lead Sponsor

BioVersys AG
All Listed Sponsors
collaborator

Clinical Research Units Hungary

OTHER

lead

BioVersys AG

INDUSTRY